Your DNA may decide which obesity drug works best
NCT ID NCT07728812
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial tests whether a simple saliva test, called MyPhenome, can guide doctors in choosing the most effective anti-obesity medication for each individual. The test sorts people into biological subtypes—like 'hungry brain' or 'hungry gut'—to personalize treatment. About 424 adults with obesity or overweight will be randomly assigned to either test-guided or standard medication selection, and their weight loss will be tracked for up to two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a genetic test (MyPhenome) that analyzes saliva to classify obesity type and guide medication choice
- What this could lead to
- If it works, this could make weight-loss treatments more effective by matching each person to the medication that best fits their biology.
- What could go wrong
- The test is new and this trial is relatively small. It may not improve outcomes enough to be worth the extra cost or effort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fiber gummies: a tasty new weapon against obesity?
- Can a diabetes drug improve joint replacement outcomes?
- Can a new pill help older adults lose weight without losing strength?
- Can one avocado a day sharpen the aging brain?
- Can a strict diet put type 2 diabetes into remission?
- Can Weight-Loss surgery alter how medications work?